Yesterday, IBM Corporation opened above $254 but ended the session below $224, marking one of its steepest single-day drops in 25 years. Since early...
Advancing Alzheimer’s and Age-Related Macular Degeneration Programs Toward FDA Engagement and IND-Enabling Activities
Targeting Initiation of Phase 1 Clinical Trial in Alzheimer’s Disease in 2027
InMed...
On Friday, we cautioned that Monday’s trading might be turbulent — though few anticipated moves of this magnitude. Over the weekend, tensions intensified dramatically...